• What is Tuberous Sclerosis
• About Our Program
• Faculty
• Research Update
• Resources for Families
• Contact
• Events
• Home

We are actively conducting a number of research projects with many more in development. We are currently enrolling individuals with TSC in research studies including:

*NEW CLINICAL TRIAL NOW ENROLLING*

• Testing the Effects of the Drug Afinitor on Cognition and Autism in Children (ages 6-21) with TSC
  
  
• More information about the clinical trial can be found at:
  

ClinicalTrials.gov

Children's Hospital Top Ten for 2010 in Science and Innovation

Children's Hospital News Room: Can drugs improve cognitive deficits in developmental disorders?

 

For more information about clinical trials from the Tuberous Sclerosis Alliance, please click here.

Ongoing Research Studies:

• Early Screening for Autism in Tuberous Sclerosis
  
  
• Genetics of Tuberous Sclerosis and Related Neurodevelopmental Disorders
  
  
• Clinical Trial for Patients with Tuberous Sclerosis and SEGA
  

For additional information regarding our research programs, please contact our study coordinators:

• Kira A. Dies at (617) 919-3009 or by email at kira.dies@childrens.harvard.edu
  
  
• Melanie Jacobs at (617) 919-3499 or by email at melanie.jacobs@childrens.harvard.edu